| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.12B | 18.14B | 14.65B | 13.13B | 12.38B | 11.80B |
| Gross Profit | 14.77B | 14.94B | 13.88B | 12.93B | 12.15B | 11.49B |
| EBITDA | 2.14B | 2.94B | 2.65B | 2.31B | 2.48B | 2.04B |
| Net Income | 1.29B | 1.58B | 1.31B | 1.06B | 1.04B | 891.00M |
Balance Sheet | ||||||
| Total Assets | 1.11T | 1.14T | 1.11T | 1.15T | 1.10T | 1.11T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 71.20B | 93.27B | 124.76B | 72.58B | 99.52B |
| Total Debt | 24.05B | 24.06B | 24.06B | 42.06B | 42.06B | 63.76B |
| Total Liabilities | 1.07T | 1.08T | 1.06T | 1.10T | 1.05T | 1.06T |
| Stockholders Equity | 48.68B | 50.82B | 47.99B | 49.90B | 47.77B | 48.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.44B | -4.33B | 0.00 | -38.59B | 11.43B |
| Operating Cash Flow | 0.00 | 4.77B | -3.98B | 0.00 | -38.20B | 12.00B |
| Investing Cash Flow | 0.00 | -51.96B | 6.61B | -4.00B | 11.73B | -8.65B |
| Financing Cash Flow | 0.00 | 25.13B | -22.53B | 48.96B | -471.00M | -467.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥27.29B | 7.83 | ― | 3.50% | 1.03% | 12.15% | |
69 Neutral | ¥14.29B | 9.59 | ― | 3.30% | 20.18% | 20.57% | |
68 Neutral | ¥12.87B | 7.27 | ― | 3.74% | 15.32% | 26.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | ¥17.73B | 9.06 | ― | 3.37% | 6.15% | -0.87% | |
58 Neutral | ¥11.51B | 11.28 | ― | 2.68% | 24.95% | 10.64% | |
52 Neutral | ¥12.87B | 17.29 | ― | 1.89% | 17.42% | ― |